PHAC says the manufacturer requires a minimum order of its updated protein-based vaccine, called Nuvaxovid, which far exceeds the uptake by Canadians last year.
McMaster Children’s Hospital says it will resume tonsil and adenoid surgeries next week, almost four months after two children died following the procedure.
Until this year, babies across Canada were only given an antibody drug that protects against severe RSV if they were born prematurely or had other significant risk factors.